Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 10:21 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 889–912 of 6,918 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Stimulation Clear all

Conditions: Dry Eye Disease
Interventions: 0.003% AR-15512 ophthalmic solution; Drug
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Newport Beach, California

Conditions: Electric Stimulation, Respiration, Artificial, Ventilator Weaning
Interventions: Breath synchronized abdominal NMES, Sham breath synchronized abdominal NMES; Device
Lead sponsor: Liberate Medical; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Breast Cancer
Interventions: aldesleukin, filgrastim, sargramostim, therapeutic autologous lymphocytes, cyclophosphamide, doxorubicin hydrochloride, paclitaxel; Biological · Drug
Lead sponsor: Roger Williams Medical Center; Other
Eligibility: 18 Years and older · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2007
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Brain and Central Nervous System Tumors, Drug/Agent Toxicity by Tissue/Organ, Lymphoma, Thrombocytopenia
Interventions: Rituxan, Cyclophosphamide, Etoposide, Etoposide phosphate, Carboplatin, Sodium thiosulfate, Neupogen, Neulasta, Cytarabine; Drug
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Months to 75 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2010
U.S. locations: 2
States / cities: Cincinnati, Ohio • Portland, Oregon

Conditions: Autism
Interventions: Spinal Manipulative Therapy (SMT), SMT and Neuromuscular Reeducation; Procedure
Lead sponsor: Southern California University of Health Sciences; Other
Eligibility: 5 Years to 15 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Whittier, California

Conditions: Spinal Cord Injuries
Interventions: Acupuncture; Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 75 Years
Enrollment: 69 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Low Back Pain, Pregnancy
Interventions: Osteopathic Manipulative Treatment, Placebo Ultrasound; Other
Lead sponsor: University of North Texas Health Science Center; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Functional Gastrointestinal Disorders (FGIDs), Cyclic Vomiting Syndrome, Functional Dyspepsia, Dysautonomia
Interventions: Percutaneous electrical nerve field stimulation, Hypnotherapy; Device · Behavioral
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 11 Years to 18 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Healthy Adults
Interventions: LIFUP, Sham LIFUP; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 45 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Normal Physiology
Interventions: continuous Theta Burst Stimulation (cTBS), intermittent Theta Burst Stimulation (iTBS), sham Theta Burst Stimulation (sham TBS); Device
Lead sponsor: National Institute on Drug Abuse (NIDA); NIH
Eligibility: 18 Years to 45 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2044
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Healthy Subjects
Interventions: Percutaneous Electrical Nerve Field Stimulation (PENFS); Device
Lead sponsor: Indiana University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 23 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Cervical Dystonia
Interventions: Transcranial magnetic stimulation (TMS); Procedure
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Depressive Disorder, Major, Depression, Mood Disorders, Mental Disorder, Psychiatric Disorder
Interventions: transcranial magnetic stimulation; Procedure
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 22 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Fear, PTSD, Panic Disorder
Interventions: Amygdala recording and stimulation using Neuropace RNS, Behavioral tasks; Device · Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Major Depressive Disorder (MDD), Treatment Resistant Depression, Major Depression
Interventions: MagVenture TMS Therapy System with Localite Navigation System and actiCHamp EEG; Device
Lead sponsor: Mayo Clinic; Other
Eligibility: 22 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Kidney Cancer, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma, Sarcoma
Interventions: filgrastim, allogeneic bone marrow transplantation; Biological · Procedure
Lead sponsor: Fred Hutchinson Cancer Center; Other
Eligibility: Up to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 2
States / cities: Nashville, Tennessee • Seattle, Washington

Conditions: Autism Spectrum Disorder, Autism, Sensory Processing Disorder, Sensory Over-Responsivity
Interventions: Sensory Habituation Protocol; Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 7 Years to 18 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Low Back Pain, Chronic Low-back Pain, Back Pain, Low, Lumbar Disc Disease, Lumbar Discogenic Pain, Lumbar Pain Syndrome, Lumbar Post-Laminectomy Syndrome, Back Pain Lower Back Chronic, Back Pain Without Radiation, Pain;Back Low;Chronic
Interventions: Cryo-auriculotherapy, Sham auriculotherapy, Experimental auricular stimulation; Device · Other
Lead sponsor: Keith M Vogt; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Breast Cancer
Interventions: filgrastim, peripheral blood stem cell transplantation, yttrium Y 90 monoclonal antibody B3; Biological · Procedure · Radiation
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2001
U.S. locations: 2
States / cities: Bethesda, Maryland

Conditions: Phantom Limb Pain
Interventions: Experimental Electrical Stimulation Regimen; Device
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Primary Progressive Aphasia
Interventions: Active tDCS plus Speech-Language Therapy, Sham plus Speech-Language Therapy; Device
Lead sponsor: Johns Hopkins University; Other
Eligibility: 50 Years to 90 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Second Trimester Abortion
Interventions: Transcutaneous Electrical Nerve Stimulation (TENS) unit, Placebo; Device
Lead sponsor: Queen's Medical Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Honolulu, Hawaii

Conditions: Intraventricular Hemorrhage
Interventions: Standard 30-60 Seconds Cord Clamping, VentFirst 120 Seconds Cord Clamping; Procedure
Lead sponsor: University of Virginia; Other
Eligibility: Not listed
Enrollment: 570 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2023
U.S. locations: 10
States / cities: Birmingham, Alabama • Sacramento, California • Denver, Colorado + 7 more

Conditions: Autism Spectrum Disorder, Intellectual Disability
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 6 Years to 65 Years
Enrollment: 164 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: Boston, Massachusetts

Search by objective public record fields.

A Study Designed to Evaluate Tear Production

Breath Synchronized Abdominal Muscle Stimulation to Facilitate Ventilator Weaning: a Pilot Study

Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

Study of Chiropractic and Neuromuscular Reeducation as a Treatment for Autism Symptoms

Acupuncture in Spinal Cord Injury Subjects

Osteopathic Manipulative Medicine in Pregnancy: Physiologic and Clinical Effects

Autonomic Reactivity and Personalized Neurostimulation

Low Intensity Focused Ultrasound Pulses (LIFUP) to Modulate Pain

Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making

ABVN Phase 2 - PENFS

Insights Into Deep Brain Stimulation (DBS) for Cervical Dystonia

Individualized Functional Connectivity Targeting in aiTBS for Depression

Investigations of Amygdala Function Using Neurophysiological Recording and Stimulation

EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease

Sensory Habituation in Autism Spectrum Disorders

AuriculoTherapy NeuroImaging

Radiolabeled Monoclonal Antibody Followed by Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Metastatic Breast Cancer

Electrical Stimulus Therapy for Chronic Phantom Limb Pain

Effects of tDCS on Apraxia of Speech in Non-Fluent Primary Progressive Aphasia

TENS Unit To Decrease Pain After Laminaria Insertion

VentFirst: A Multicenter RCT of Assisted Ventilation During Delayed Cord Clamping for Extremely Preterm Infants

TMS for the Investigation of Brain Plasticity in Autism Spectrum Disorders